checkAd
    Startseite > Aktien > Lisata Therapeutics > Nachrichten
    Lisata Therapeutics Aktie
    3,0100
     
    USD
    +5,24 %
    +0,1500 USD
    Letzter Kurs 02:00:00 Nasdaq
    3,0100
     
    USD
    100 STK
    Geldkurs 21.05.24
    3,1000
     
    USD
    200 STK
    Briefkurs 21.05.24
    ISIN: US1280583022 · WKN: A3DWGC · SYM: LSTA · USA

    Neueste Nachrichten

    Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
    20.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    09.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
    08.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
    02.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    23.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
    09.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
    03.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
    21.03.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    29.02.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4: 30 p.m. Eastern Time
    22.02.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Present at BIO CEO & Investor Conference
    20.02.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme
    17.01.24 · globenewswire · Lisata Therapeutics